Found 1304 clinical trials
Program_Basrah12
This test can detect abnormal levels of certain proteins in the blood, which can be an early sign of myeloma.
- 0 views
- 28 Nov, 2024
A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine
The reason for this 12-month, open-label study is to see if the study drug lasmiditan is safe and effective for the intermittent acute treatment of migraine in children aged 6 to 17. The study will last about 12 months and may include up to 7 visits.
- 0 views
- 19 Feb, 2024
A Mobile Application for Telerehabilitation in Parkinson's Disease
The purpose of this study is to determine if the 9zest app for Parkinson's disease is feasible, safe, and efficacious when used independently by individuals with Parkinson's disease.
- 20 views
- 19 Feb, 2024
- 1 location
Additional_prescreening_Automation_Study
Additional_prescreening_Automation_Study
- 0 views
- 29 Feb, 2024
RJ_Study1
Pimples:Take up this questionnaire to help us determine if you have symptoms that are common to this clinical study. If you have the common symptoms, you may be eligible to take part in the study.
- 0 views
- 19 Feb, 2024
- 2 locations
Personalizing Sleep Interventions to Prevent Type 2 Diabetes in Community Dwelling Adults With Pre-Diabetes
Sleep extension and habitual sleep groups will complete daily sleep diaries and participate in a weekly 15-minute telephone call or videoconference meeting with a member of the study team (8 sessions total). Data collection will be at 2 time points: pre-randomization and post-intervention (completion of the 8-week intervention). Changes in …
- 0 views
- 19 Feb, 2024
A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease
This is a multicenter randomized, double-blind, placebo-controlled Phase 2 study designed to evaluate the efficacy, safety, and tolerability of two doses of CT1812 compared to placebo in participants diagnosed with early Alzheimer's disease.
- 0 views
- 19 Feb, 2024
- 1 location
A5418 Study of Tecovirimat for Human Monkeypox Virus (STOMP)
Participants will be seen at day 57 to assess for possible recrudescence of infection (i.e., new lesions occurring after initial resolution of disease.
- 0 views
- 19 Feb, 2024
- 1 location
test website import(please dont visit)
For more information and details, they can head over to the website of Vedantu. The Vedantu app can also be downloaded and skimmed through for more ease while studying...................................................................................................................
- 0 views
- 27 Sep, 2024
- 2 locations
Testing for COVID-19 in High Risk Children With Intellectual and Developmental Disabilities (COV-IDD)
Is there any hesitancy to get the vaccine and what are the reasons? This information will be used to help keep the school open and the students and staff safe. Eligible participants are those that work at the Mary Cariola Center (MCC) and interact with the students at MCC who …
- 0 views
- 19 Feb, 2024